C35H32N6O2, triclinic, P1‾$‾{1}$ (no. 2), a = 10.902(2) Å, b = 12.434(2) Å, c = 13.481(4) Å, α = 102.881(5)°, β = 104.935(5)°, γ = 114.542(3)°, V = 1488.6(6) Å3, Z = 2, Rgt(F) = 0.0511, wRref(F2) = 0.1429, T = 296 K
The title compound, C31H26N4O2S, crystallizes in a triclinic centrosymmetric lattice with two molecu...
In the title molecule, C30H36N4O3, the dihedral angle between the planes of the xanthene and spirola...
C37H36N6O2, monoclinic, P21/c (no. 14), a = 9.18664(12) Å, b = 14.50209(16) Å, c = 23.1787(3) Å, β =...
C32H31N5O2, triclinic, P1̄ (no. 2), a = 9.9226(4) Å, b = 11.1446(7) Å, c = 12.6719(6) Å, α = 90.693(...
C34H34N5O2Br, orthorhombic Pca21 (no. 29), a = 21.3626(13) Å, b = 11.8358(8) Å, c = 12.0998(9) Å, Z ...
C38H45N5O5, triclinic, P1‾ (no. 2), a = 11.3541(16) Å, b = 12.1833(17) Å, c = 14.409(2) Å, α = 68.24...
In the title compound, C35H27N3O3S, the spiro-linked five-membered rings both adopt twisted conforma...
C24H29N5O, triclinic, P1̄ (no. 2), a = 10.352(9) Å, b = 10.911(10) Å, c = 12.480(6) Å, α = 97.33(2)°...
C17H15NO, monoclinic, C2/c (no. 15), a = 19.197(2) Å, b = 8.0719(8) Å, c = 16.6511(18) Å, α = 90°, β...
In the title compound, C35H30N4O3, the spiro C atom connects the five-membered pyrrolidine ring and ...
C26H18N2O8, triclinic, P1̅ (no. 2), a = 7.7679(19) Å, b = 11.000(3) Å, c = 13.370(3) Å, α = 75.682(5...
C19H18N4O, monoclinic, P21/c (no. 14), a = 11.3744(16) Å, b = 13.7367(15) Å, c = 11.208(2) Å, β = 11...
C30H31NO8, triclinic, P‾$\overline{P}$1 (no. 2), a = 5.21720(10) Å, b = 9.2878(2) Å, c = 27.2825(5) ...
C26H36N6, triclinic, P1‾$\overline{1}$ (no. 2), a = 5.7137(2) Å, b = 10.4374(3) Å, c = 11.1141(3) Å,...
C21H26N2O6, triclinic P1̅ (no. 2), a = 8.1553(5) Å, b = 9.0739(9) Å, c = 14.6857(14) Å, α = 100.648(...
The title compound, C31H26N4O2S, crystallizes in a triclinic centrosymmetric lattice with two molecu...
In the title molecule, C30H36N4O3, the dihedral angle between the planes of the xanthene and spirola...
C37H36N6O2, monoclinic, P21/c (no. 14), a = 9.18664(12) Å, b = 14.50209(16) Å, c = 23.1787(3) Å, β =...
C32H31N5O2, triclinic, P1̄ (no. 2), a = 9.9226(4) Å, b = 11.1446(7) Å, c = 12.6719(6) Å, α = 90.693(...
C34H34N5O2Br, orthorhombic Pca21 (no. 29), a = 21.3626(13) Å, b = 11.8358(8) Å, c = 12.0998(9) Å, Z ...
C38H45N5O5, triclinic, P1‾ (no. 2), a = 11.3541(16) Å, b = 12.1833(17) Å, c = 14.409(2) Å, α = 68.24...
In the title compound, C35H27N3O3S, the spiro-linked five-membered rings both adopt twisted conforma...
C24H29N5O, triclinic, P1̄ (no. 2), a = 10.352(9) Å, b = 10.911(10) Å, c = 12.480(6) Å, α = 97.33(2)°...
C17H15NO, monoclinic, C2/c (no. 15), a = 19.197(2) Å, b = 8.0719(8) Å, c = 16.6511(18) Å, α = 90°, β...
In the title compound, C35H30N4O3, the spiro C atom connects the five-membered pyrrolidine ring and ...
C26H18N2O8, triclinic, P1̅ (no. 2), a = 7.7679(19) Å, b = 11.000(3) Å, c = 13.370(3) Å, α = 75.682(5...
C19H18N4O, monoclinic, P21/c (no. 14), a = 11.3744(16) Å, b = 13.7367(15) Å, c = 11.208(2) Å, β = 11...
C30H31NO8, triclinic, P‾$\overline{P}$1 (no. 2), a = 5.21720(10) Å, b = 9.2878(2) Å, c = 27.2825(5) ...
C26H36N6, triclinic, P1‾$\overline{1}$ (no. 2), a = 5.7137(2) Å, b = 10.4374(3) Å, c = 11.1141(3) Å,...
C21H26N2O6, triclinic P1̅ (no. 2), a = 8.1553(5) Å, b = 9.0739(9) Å, c = 14.6857(14) Å, α = 100.648(...
The title compound, C31H26N4O2S, crystallizes in a triclinic centrosymmetric lattice with two molecu...
In the title molecule, C30H36N4O3, the dihedral angle between the planes of the xanthene and spirola...
C37H36N6O2, monoclinic, P21/c (no. 14), a = 9.18664(12) Å, b = 14.50209(16) Å, c = 23.1787(3) Å, β =...